NEW ORLEANS, Jan. 10, 2020 /PRNewswire/ -- LongueVue Capital
Partners ("LVC"), a partnership-driven, operator-centric private
equity firm based in New Orleans
with approximately $500 million of
assets under management, announced today that Geoff Glass and Pete
Allen have joined the firm as healthcare Operating Partners.
Geoff, a seasoned pharma services executive, will focus on the life
science space. Pete, a healthcare executive with broad reaching
experience, will focus on medical devices and related contract
services as well as healthcare supply chain services. The additions
of both Pete and Geoff reiterate LVC's commitment to the healthcare
industry, which is one of the firm's largest investment
verticals.
Geoff brings a wealth of experience in the life science and
pharmaceutical space. Geoff began his career in life science
consulting at Ernst & Young before jumping into the industry at
ICN Pharmaceuticals, which eventually became Valeant
Pharmaceuticals. Since then, Geoff has held senior executive roles
at Valeant Pharmaceuticals and Patheon across both sales and
operations functions. Before becoming President of Patheon's Banner
Life Sciences business unit, Geoff served as the Executive Vice
President of Global Sales and Marketing. More recently, Geoff was
CEO of Sancilio Pharmaceuticals and has served on a number of life
science boards, including Locus Biosciences. Geoff is currently
Chairman of the Board of Avadel Pharmaceuticals (NASDAQ:AVDL).
Across all his roles, Geoff has been instrumental in developing and
growing companies with differentiated service and/or product
offerings.
Pete has an impressive background as a senior healthcare
executive across a variety of healthcare verticals with specific
expertise in P&L management, business development, sales,
marketing, distribution management, regulatory affairs, political
lobbying, group purchasing, research and development,
manufacturing, M&A integration, and new product/business
launches. Most recently, Pete was the Executive Vice President of
sourcing operations at Vizient (from 2010 to 2019), the largest
group purchasing organization in the
United States with over 3,500 employees. Prior to Vizient,
Pete served as Vice President and General Manager of the infusion
therapy division at Becton Dickinson (NYSE: BDX), a $650 million business unit. Pete also held
numerous sales positions at Kimberly-Clark Healthcare, ultimately
serving as Director of Global Strategic Marketing. Through his
entire career, Pete has led growth transformations and built
established, defendable market-leading healthcare companies.
Ryan Nagim, LVC Partner who helps
lead the firm's healthcare investment strategy, commented, "Both
Geoff and Pete have deep operating experience that will serve as a
tremendous resource to our firm and expand LVC's ability to create
meaningful value within our healthcare portfolio. Specifically,
Geoff and Pete will work with LVC and our management team partners
to enhance each company's value proposition through operational
improvement, technological enhancement, customer and service-line
expansion, synergistic add-on acquisitions, and prudent deployment
of financial and human capital. We are incredibly excited to launch
these partnerships."
Rick Rees, LVC's Co-Founder and
Managing Partner, added, "In working with Pete and Geoff, it is
clear that both place the same value in partnerships as we do. Both
are tremendous cultural fits with LVC, making them ideal partners
to help guide our healthcare investments through the next phase of
growth."
Within life sciences, LVC will focus on companies that have
differentiated capabilities in contract development, manufacturing
and lab services; ingredient or equipment suppliers essential to
drug manufacturing or delivery; and value-added service providers
or suppliers to the cell and gene therapy market, including cold
chain logistics. LVC will also target businesses with niche product
or service offerings within the pharmaceutical, biopharma,
nutritional, and/or consumer health sectors as well as
mission-critical software and quality and compliance offerings
serving the life science sector.
Geoff noted, "Over the past three years, I've developed a deep
relationship with the LVC team. I'm thrilled to formally join the
team in a position where I can add value to scalable companies in a
highly dynamic and rapidly changing sector. While I've had the
pleasure of working with many private equity firms over the years,
I remain extremely impressed with LVC's culture, and their unique
operator-centric and partnership-driven approach to investing."
Pete will support expanding LVC's healthcare portfolio in the
packaging and supply chain segments, low- to mid-tech medical
device segments, and medical equipment capital management and
disposal segments. Pete will also focus on opportunities that
reduce costs to the provider community.
Pete commented, "I've developed a strong relationship with the
LVC team over the past few years and have worked with a number of
their portfolio companies. I am impressed by the LVC team's
partnership approach and their ability to drive sustainable growth
within their healthcare portfolio. I am extremely excited to
partner with LVC and leverage my multi-disciplinary healthcare
expertise to expand the firm's presence across multiple healthcare
sectors."
About LongueVue Capital Partners
Founded in 2001, LongueVue Capital is a New Orleans-based private equity firm that
focuses on providing human capital, financial capital, and a skill
set built upon a successful 19-year track record of partnering with
entrepreneurs and management teams to drive value creation in
middle market companies. Having managed over $500 million of capital spanning three funds
coupled with 150 years of combined operating and investing
experience, our team is the ideal partner for middle market
companies at inflection points and seeking to maximize value.
Our opportunistic investment strategy provides the flexibility
to partner with attractive businesses across a variety of
industries and situations, and we tailor transaction structures to
meet company and stakeholders' objectives. While we are selective
with our investment strategy, we target growth-oriented companies
with scalable, sustainable business models and exceptional
leadership teams.
Our proactive, hands-on approach enables us to be thoughtful
stewards of our portfolio companies and trusted and dependable
strategic partners to all stakeholders. Together with our
entrepreneur and management team partners, we help create superior
value for our portfolio companies and investors.
To learn more about LongueVue Capital, please visit our website
at www.lvcpartners.com, and to learn more about our healthcare
portfolio and investment approach, please visit our healthcare
themes and portfolio page at
www.lvcpartners.com/portfolio/healthcare. For inquiries, please
contact Ryan Nagim, Partner, at
rnagim@lvcpartners.com or call 504.293.3600.
View original
content:http://www.prnewswire.com/news-releases/longuevue-capital-adds-experienced-healthcare-operating-partners-to-support-new--existing-investments-300984194.html
SOURCE LongueVue Capital Partners